Precision medicine in fatty liver disease/non-alcoholic fatty liver disease
L Valenzuela-Vallejo, D Sanoudou… - Journal of Personalized …, 2023 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease, and is
related to fatal and non-fatal liver, metabolic, and cardiovascular complications. Its non …
related to fatal and non-fatal liver, metabolic, and cardiovascular complications. Its non …
What Is in a Name: from NAFLD to MAFLD and MASLD—Unraveling the Complexities and Implications
MM Ramírez-Mejía, N Méndez-Sánchez - Current Hepatology Reports, 2023 - Springer
Abstract Purpose of Review This review aims to examine the evolution of terminology,
diagnostic criteria, epidemiologic considerations, and clinical implications of the change …
diagnostic criteria, epidemiologic considerations, and clinical implications of the change …
[HTML][HTML] Prevalence and clinical outcomes in subtypes of metabolic associated fatty liver disease
KL Cheng, SW Wang, YM Cheng, TH Hsieh… - Journal of the Formosan …, 2024 - Elsevier
Background/purpose In 2020, metabolic Associated Fatty Liver Disease (MAFLD) was
proposed to replace non-alcoholic fatty liver disease (NAFLD) with new diagnostic criteria …
proposed to replace non-alcoholic fatty liver disease (NAFLD) with new diagnostic criteria …
[HTML][HTML] FLAME: Training and Validating a Newly Conceived Model Incorporating Alpha-Glutathione-S-Transferase Serum Levels for Predicting Advanced Hepatic …
M Dallio, M Romeo, F Di Nardo, P Vaia… - International Journal of …, 2025 - mdpi.com
Alpha-Glutathione-S-transferase (alphaGST) is a liver enzyme whose serum levels increase
with the worsening of fibrosis in alcoholic and viral chronic hepatitis. Its usefulness in …
with the worsening of fibrosis in alcoholic and viral chronic hepatitis. Its usefulness in …
Design, synthesis, and biological evaluation of imidazo [4, 5-b] pyridine mitochondrial uncouplers for the treatment of metabolic dysfunction-associated steatohepatitis …
JM Salamoun, EL Krinos, MA Foutz, SR Hargett… - European Journal of …, 2024 - Elsevier
Small molecule mitochondrial uncouplers have gained traction for their potential therapeutic
use against metabolic dysfunction-associated steatohepatitis (MASH). Herein, we report a …
use against metabolic dysfunction-associated steatohepatitis (MASH). Herein, we report a …